For instance, a radiomics model using PET/CT images predicted COX-2 expression in cervical cancer, achieving moderate performance (AUC = 0.748 in the internal test set), but its clinical applicability was limited by small sample sizes and lack of independent validation [36]. This evidence concerns the gene PTGS2 and cervical cancer.